| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5599403 | Atherosclerosis | 2017 | 7 Pages |
Abstract
Plasma suPAR level is predictive of prevalent PAD and of incident cardiovascular and PAD-related events. Whether SuPAR measurement can help screen, risk stratify, or monitor therapeutic responses in PAD requires further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ayman Samman Tahhan, Salim S. Hayek, Pratik Sandesara, Jamal Hajjari, Muhammad Hammadah, Wesley T. O'Neal, Heval M. Kelli, Ayman Alkhoder, Nima Ghasemzadeh, Yi-An Ko, Hiroshi Aida, Mohamad Mazen Gafeer, Naser Abdelhadi, Kareem Hosny Mohammed,